NO20041732L - Anvendelse av irbesartan for fremstilling av medikamenter som anvendes for a forhindre eller behandle pulmonal hypertensjon - Google Patents

Anvendelse av irbesartan for fremstilling av medikamenter som anvendes for a forhindre eller behandle pulmonal hypertensjon

Info

Publication number: NO20041732L
Authority: NO; Norway
Prior art keywords: irbesartan; manufacture; prevent; pulmonary hypertension; treat pulmonary
Prior art date: 2001-10-26

Application number

NO20041732A

Other languages

English (en)

Other versions

NO332313B1 (no

Inventor

Dino Nisato

Sylvie Cosnier-Pucheu

Alain Roccon

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-26

Filing date

2004-04-23

Publication date

2004-07-23

2004-04-23 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2004-07-23 Publication of NO20041732L publication Critical patent/NO20041732L/no

2012-08-27 Publication of NO332313B1 publication Critical patent/NO332313B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)

NO20041732A 2001-10-26 2004-04-23 Anvendelse av irbesartan for fremstilling av medisinske produkter som er anvendbare for a forebygge eller behandle pulmonal arteriell hypertensjon eller pulmonal hypertensjon NO332313B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0113936A FR2831446B1 (fr)	2001-10-26	2001-10-26	Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire
PCT/FR2002/003439 WO2003035062A1 (fr)	2001-10-26	2002-10-09	Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire

Publications (2)

Publication Number	Publication Date
NO20041732L true NO20041732L (no)	2004-07-23
NO332313B1 NO332313B1 (no)	2012-08-27

Family

ID=8868812

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20041732A NO332313B1 (no)	2001-10-26	2004-04-23	Anvendelse av irbesartan for fremstilling av medisinske produkter som er anvendbare for a forebygge eller behandle pulmonal arteriell hypertensjon eller pulmonal hypertensjon

Country Status (24)

Country	Link
US (2)	US20040242567A1 (no)
EP (1)	EP1441723B1 (no)
JP (1)	JP4542777B2 (no)
CN (1)	CN100418526C (no)
AT (1)	ATE361071T1 (no)
AU (1)	AU2002350832B2 (no)
BR (1)	BR0213479A (no)
CA (1)	CA2461625C (no)
CY (1)	CY1106746T1 (no)
DE (1)	DE60219940T2 (no)
DK (1)	DK1441723T3 (no)
EA (1)	EA007952B1 (no)
ES (1)	ES2286304T3 (no)
FR (1)	FR2831446B1 (no)
HU (1)	HUP0401633A3 (no)
IL (2)	IL161116A0 (no)
IS (1)	IS2849B (no)
MX (1)	MXPA04003910A (no)
NO (1)	NO332313B1 (no)
NZ (1)	NZ532130A (no)
PL (1)	PL209263B1 (no)
PT (1)	PT1441723E (no)
WO (1)	WO2003035062A1 (no)
ZA (1)	ZA200402696B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8912174B2 (en)	2003-04-16	2014-12-16	Mylan Pharmaceuticals Inc.	Formulations and methods for treating rhinosinusitis
US7811606B2 (en)	2003-04-16	2010-10-12	Dey, L.P.	Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en)	2003-04-16	2017-11-07	Mylan Specialty Lp	Nasal pharmaceutical formulations and methods of using the same
US20040265238A1 (en) *	2003-06-27	2004-12-30	Imtiaz Chaudry	Inhalable formulations for treating pulmonary hypertension and methods of using same
TR200301553A1 (tr) *	2003-09-18	2005-10-21	Nobel �La� Sanay�� Ve T�Caret A.�.	İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
CA2568640C (en)	2004-06-04	2011-08-09	Teva Pharmaceutical Industries Ltd.	Pharmaceutical composition containing irbesartan
WO2006067601A1 (en) *	2004-12-23	2006-06-29	Ranbaxy Laboratories Limited	Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation
CN100367959C (zh) *	2006-08-29	2008-02-13	陈俊云	一种含有依贝沙坦的药物
GB0617171D0 (en) *	2006-08-31	2006-10-11	Generics Uk Ltd	Novel compositions and methods
US20240173302A1 (en) *	2021-03-23	2024-05-30	Dimerix Bioscience Pty Ltd	Treatment of inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5258510A (en) *	1989-10-20	1993-11-02	Otsuka Pharma Co Ltd	Benzoheterocyclic compounds
US5270317A (en) *	1990-03-20	1993-12-14	Elf Sanofi	N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
TW201738B (no) *	1990-03-20	1993-03-11	Sanofi Co
RU2086544C1 (ru) *	1991-06-13	1997-08-10	Хоффманн-Ля Рош АГ	Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
US5292741A (en) *	1992-08-18	1994-03-08	Merck & Co., Inc.	Macrocycles incorporating quinazolinones
US20020068740A1 (en)	1999-12-07	2002-06-06	Mylari Banavara L.	Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications

2001
- 2001-10-26 FR FR0113936A patent/FR2831446B1/fr not_active Expired - Fee Related
2002
- 2002-10-09 CA CA2461625A patent/CA2461625C/en not_active Expired - Fee Related
- 2002-10-09 PT PT02785535T patent/PT1441723E/pt unknown
- 2002-10-09 AT AT02785535T patent/ATE361071T1/de active
- 2002-10-09 DK DK02785535T patent/DK1441723T3/da active
- 2002-10-09 NZ NZ532130A patent/NZ532130A/en not_active IP Right Cessation
- 2002-10-09 HU HU0401633A patent/HUP0401633A3/hu unknown
- 2002-10-09 EP EP02785535A patent/EP1441723B1/fr not_active Expired - Lifetime
- 2002-10-09 ES ES02785535T patent/ES2286304T3/es not_active Expired - Lifetime
- 2002-10-09 WO PCT/FR2002/003439 patent/WO2003035062A1/fr not_active Ceased
- 2002-10-09 CN CNB028213041A patent/CN100418526C/zh not_active Expired - Fee Related
- 2002-10-09 MX MXPA04003910A patent/MXPA04003910A/es active IP Right Grant
- 2002-10-09 PL PL368737A patent/PL209263B1/pl unknown
- 2002-10-09 JP JP2003537629A patent/JP4542777B2/ja not_active Expired - Fee Related
- 2002-10-09 AU AU2002350832A patent/AU2002350832B2/en not_active Ceased
- 2002-10-09 US US10/492,804 patent/US20040242567A1/en not_active Abandoned
- 2002-10-09 BR BR0213479-9A patent/BR0213479A/pt not_active Application Discontinuation
- 2002-10-09 EA EA200400438A patent/EA007952B1/ru not_active IP Right Cessation
- 2002-10-09 IL IL16111602A patent/IL161116A0/xx unknown
- 2002-10-09 DE DE60219940T patent/DE60219940T2/de not_active Expired - Lifetime
2004
- 2004-03-25 IL IL161116A patent/IL161116A/en not_active IP Right Cessation
- 2004-03-29 IS IS7200A patent/IS2849B/is unknown
- 2004-04-06 ZA ZA2004/02696A patent/ZA200402696B/en unknown
- 2004-04-23 NO NO20041732A patent/NO332313B1/no not_active IP Right Cessation
2007
- 2007-07-19 CY CY20071100964T patent/CY1106746T1/el unknown
2009
- 2009-06-03 US US12/477,562 patent/US8088827B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2002350832B2 (en)	2006-11-30
US8088827B2 (en)	2012-01-03
MXPA04003910A (es)	2004-07-23
FR2831446B1 (fr)	2004-03-05
IS7200A (is)	2004-03-29
DK1441723T3 (da)	2007-09-10
EA200400438A1 (ru)	2004-10-28
CA2461625C (en)	2011-07-05
EA007952B1 (ru)	2007-02-27
WO2003035062A1 (fr)	2003-05-01
DE60219940T2 (de)	2008-01-17
JP4542777B2 (ja)	2010-09-15
CN1610548A (zh)	2005-04-27
EP1441723A1 (fr)	2004-08-04
DE60219940D1 (de)	2007-06-14
IS2849B (is)	2013-09-15
HUP0401633A3 (en)	2009-06-29
NO332313B1 (no)	2012-08-27
US20090247510A1 (en)	2009-10-01
HUP0401633A2 (hu)	2004-12-28
EP1441723B1 (fr)	2007-05-02
CA2461625A1 (en)	2003-05-01
BR0213479A (pt)	2004-11-03
FR2831446A1 (fr)	2003-05-02
NZ532130A (en)	2006-10-27
CN100418526C (zh)	2008-09-17
PT1441723E (pt)	2007-07-26
PL368737A1 (en)	2005-04-04
ES2286304T3 (es)	2007-12-01
JP2005506369A (ja)	2005-03-03
IL161116A (en)	2010-12-30
CY1106746T1 (el)	2012-05-23
US20040242567A1 (en)	2004-12-02
ATE361071T1 (de)	2007-05-15
PL209263B1 (pl)	2011-08-31
IL161116A0 (en)	2004-08-31
ZA200402696B (en)	2005-06-29

Publication	Publication Date	Title
NL300933I2 (nl)	2018-04-26	Letermovir
NO20052626D0 (no)	2005-05-31	Middel for forhindring eller behandling av neuropati
TNSN05045A1 (en)	2007-05-14	Indole or benzimidazole derivatives for modulating ikappab kinase
HUP0303363A2 (hu)	2004-07-28	Kináz-inhibitor hatású heterociklusos vegyületek alkalmazása gyógyszerkészítmények előállítására
NO20071343L (no)	2007-05-30	Substituerte fenylaminotiazoler og anvendelse derav
MXPA03010134A (es)	2004-03-10	Derivados de ciclohexan-1-4-diamina sustituidos.
NO20055863L (no)	2001-09-12	W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
ATE408601T1 (de)	2008-10-15	Fredericamycin-derivate
UY28931A1 (es)	2005-12-30	Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
DK1456212T3 (da)	2007-04-02	6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
DE60132851D1 (de)	2008-04-03	Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
NO20041732L (no)	2004-07-23	Anvendelse av irbesartan for fremstilling av medikamenter som anvendes for a forhindre eller behandle pulmonal hypertensjon
DK1246808T3 (da)	2011-12-05	1,2-diarylbenzimidazoler til behandling af sygdomme, som er associeret med en mikroglia-aktivering
NO20076405L (no)	2008-02-11	Anvendelse av 24-nor-UDCA
WO2002010152A3 (de)	2002-08-01	Neue indolderivate und deren verwendung als arzneimittel
CY1109950T1 (el)	2014-09-10	Νεα παραγωγα 4,4-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικων) και συνθεσεις που τα περιεχουν
NO20033318L (no)	2003-09-24	2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
AU2002350832A1 (en)	2003-07-03	Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
MXPA04004090A (es)	2004-07-08	Compuestos substituidos de 1h-quinolin-2-ona.
WO2008131859A3 (de)	2009-07-16	Verwendimg cyclisch substituierter furopyrimidin-derivate zur behandlung der pulmonalen arteriellen hypertonie
DE60023154D1 (de)	2006-02-23	Alkoxy-substituierte benzimidazolverbindungen , diese enthaltende arzneimittel und ihre verwendung
CY1110737T1 (el)	2015-06-10	Υποκατεστημενες ενωσεις 1,5-διαμινοπενταν-3-ολης
DK1425007T3 (da)	2006-03-13	Anvendelse af C2-substituerede indan-1-ol-systemer til fremstilling af medikamenter til profylaxe eller behandling af obesitas
NO20034998D0 (no)	2003-11-10	Citalopram til behandling av forhöyet blodtrykk
HK1065488A (en)	2005-02-25	Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension

Legal Events

Date	Code	Title	Description
2015-05-26	MM1K	Lapsed by not paying the annual fees